Loading the section
The price of Strata Critical Medical, Inc. (SRTA) on October 9, 2026 is 4.53 USD, +1.34% on the day. Over 52 weeks the stock traded between 3.95 USD and 6.50 USD; the price now sits 23% of the way up that range. Over the past year the price changed by -8.85%. The P/E ratio is 8.4, which is below the sector median (25.0). Market capitalization is 392.76 million USD, rank 8 among 11 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Strata Critical Medical, Inc. trades on Nasdaq under the ticker SRTA. The company belongs to the Health care sector. The trading history on this page starts on 05 November 2019.
Over the past 52 weeks SRTA has traded between 3.95 $ and 6.50 $. As of 09 October 2026 the price stood 22.75 % of the way from the 52-week low to the high.
Over one year SRTA shares fell 8.85 %; over six months they rose 12.13 %. Volatility over 90 days is 46.12 %. Dividends are not included: this is price change only, as of 09 October 2026.
SRTA trades at a price-to-earnings ratio of 8.4, below the sector median of 25.0. Price to sales is 1.9, below the sector median of 4.0. Price to book is 1.4, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 4.47 | 4.58 | 4.40 | 4.53 | 623,100 |
| 08 October 2026 | 4.65 | 4.65 | 4.46 | 4.47 | 1M |
| 07 October 2026 | 4.74 | 4.74 | 4.65 | 4.68 | 703,900 |
| 06 October 2026 | 4.84 | 4.86 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:31 HUDSON YARDS 14TH FLOOR, NEW YORK, NY, 10001, US
Strata Critical Medical, Inc. reported revenue of 210M $ and net income of 47M $ over the last four quarters. Net margin is 22.35 %. Revenue changed by +40.51 % year over year. Earnings per share are 0.57 $. Market capitalisation is 393M $.
SRTA has a return on equity of 16.45 %, above the sector median of −41.68 %. Return on assets is 14.34 %, above the sector median of −32.11 %. Operating margin is −8.44 %, above the sector median of −26.84 %.
| 26M |
| PNTGThe Pennant Group, Inc. | 39.73 | −1.59 % | 15M |
| USPHU.S. Physical Therapy, Inc. | 84.67 | +1.38 % | 14M |
| INNVInnovAge Holding Corp. | 9.10 | −0.11 % | 7M |
| EUDAEuda Health Holdings Limited | 18.48 | −0.67 % | 397,752 |
| 4.72 |
| 4.75 |
| 760,500 |
| 05 October 2026 | 4.76 | 4.91 | 4.69 | 4.81 | 1M |
| 02 October 2026 | 4.90 | 4.93 | 4.71 | 4.73 | 999,600 |
| 01 October 2026 | 5.12 | 5.12 | 4.80 | 4.83 | 2M |
| 30 September 2026 | 5.13 | 5.18 | 5.08 | 5.11 | 798,300 |
| 29 September 2026 | 5.29 | 5.34 | 5.01 | 5.10 | 1M |
| 28 September 2026 | 5.25 | 5.30 | 5.14 | 5.23 | 654,300 |
| 25 September 2026 | 5.28 | 5.40 | 5.20 | 5.33 | 519,600 |
| 24 September 2026 | 5.33 | 5.41 | 5.23 | 5.27 | 618,800 |
| 23 September 2026 | 5.43 | 5.52 | 5.31 | 5.38 | 895,500 |
| 22 September 2026 | 5.46 | 5.50 | 5.33 | 5.48 | 666,300 |
| 21 September 2026 | 5.40 | 5.47 | 5.32 | 5.40 | 573,600 |
| 18 September 2026 | 5.40 | 5.49 | 5.24 | 5.34 | 896,500 |
| 17 September 2026 | 5.30 | 5.42 | 5.29 | 5.38 | 571,500 |
| 16 September 2026 | 5.30 | 5.35 | 5.13 | 5.22 | 525,800 |
| 15 September 2026 | 5.31 | 5.40 | 5.20 | 5.29 | 544,800 |
| 14 September 2026 | 5.11 | 5.42 | 5.11 | 5.36 | 1M |